Pharmaceuticals & Biotech South African Community
Our community narratives are driven by numbers and valuation.
Pharmaceuticals & Biotech South African Investing Ideas
Commercial Pharma And GLP-1 Expansion Will Empower Future Progress
Key Takeaways Steady commercial pharma growth through strategic market focus in China and Russia enhances revenue stability. GLP-1 and insulin manufacturing expansion offers substantial long-term revenue and margin growth potential.Read more
AN
R120.6
31.5% overvalued intrinsic discount
Fair Value
Profit Margin
13.23%
Future PE
12.59x
Price in 2028
R191.73
